Jennette J C, Feldman J D
J Immunol. 1978 Nov;121(5):1696-700.
Complexes of 125I p30, a viral core polypeptide, and rat anti-p30 antibody, preformed in vitro, were injected into the heart of BN rats bearing Moloney sarcomas (MST) and of BN rats bearing an unrelated tumor or unexposed to tumor. Complexes were cleared from the circulation of MST-bearing rats more rapidly than from sera of controls and were almost completely eliminated after 30 hr. There was no relationship between rate of disappearance and size of tumor or levels of circulating complexes. Disappearance rates in rats with progressing and regressing tumors were similar. Uncomplexed labeled p30 was cleared from the circulation of tumor-bearing and control rats with kinetics similar to those of labeled complexes. Complexes were localized in the spleen of tumor-bearing and control rats, but much more in spleens of MST-bearing rats. No other tissues, including tumor, concentrated complexes, nor was there binding to peripheral blood and spleen cells. The data suggest that augmented clearance and sequestration were due to the formation of large insoluble complexes that were rapidly removed by the reticulo-endothelial system.
在体外预先形成的125I p30(一种病毒核心多肽)与大鼠抗p30抗体的复合物,被注射到患有莫洛尼肉瘤(MST)的BN大鼠以及患有无关肿瘤或未接触肿瘤的BN大鼠的心脏中。与对照组血清相比,复合物从患有MST的大鼠循环中清除得更快,30小时后几乎完全清除。消失速率与肿瘤大小或循环复合物水平之间没有关系。肿瘤进展和消退的大鼠的消失速率相似。未复合的标记p30从荷瘤大鼠和对照大鼠的循环中清除,其动力学与标记复合物相似。复合物定位于荷瘤大鼠和对照大鼠的脾脏中,但在患有MST的大鼠脾脏中更多。没有其他组织,包括肿瘤,会浓缩复合物,外周血和脾细胞也没有结合。数据表明,清除和隔离增加是由于形成了大的不溶性复合物,这些复合物被网状内皮系统迅速清除。